|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.60 USD | -0.14% |
|
-3.45% | +11.49% |
| May. 07 | Travere Therapeutics Prices Upsized $475 Million Debt Offering | MT |
| May. 07 | Travere Therapeutics Insider Sold Shares Worth $988,875, According to a Recent SEC Filing | MT |
| Capitalization | 3.96B 3.37B 3.08B 2.91B 5.42B 374B 5.47B 36.54B 14.24B 180B 14.86B 14.55B 620B | P/E ratio 2026 * |
183x | P/E ratio 2027 * | 18x |
|---|---|---|---|---|---|
| Enterprise value | 3.95B 3.36B 3.07B 2.9B 5.41B 373B 5.46B 36.47B 14.22B 179B 14.83B 14.52B 619B | EV / Sales 2026 * |
5.65x | EV / Sales 2027 * | 3.78x |
| Free-Float |
94.65% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Travere Therapeutics, Inc.
| 1 day | -0.14% | ||
| 1 week | -3.45% | ||
| Current month | +1.14% | ||
| 1 month | +35.50% | ||
| 3 months | +41.67% | ||
| 6 months | +31.73% | ||
| Current year | +11.49% |
| 1 week | 41.77 |  | 48.61 |
| 1 month | 28.38 | | 48.61 |
| Current year | 22.59 | | 48.61 |
| 1 year | 13.88 | | 48.61 |
| 3 years | 5.12 | | 48.61 |
| 5 years | 5.12 | | 48.61 |
| 10 years | 5.12 | | 48.61 |
| Manager | Title | Age | Since |
|---|---|---|---|
Eric Dube
CEO | Chief Executive Officer | 53 | 2019-01-03 |
Chris Cline
DFI | Director of Finance/CFO | 42 | 2022-08-30 |
Jula Inrig
CTO | Chief Tech/Sci/R&D Officer | 51 | 2022-01-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Gary Lyons
CHM | Chairman | 75 | 2016-05-17 |
Jeffrey Meckler
CHM | Chairman | 59 | 2015-06-07 |
Tim Coughlin
BRD | Director/Board Member | 59 | 2015-03-30 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.14% | -3.45% | +112.79% | +156.94% | 3.96B | |
| -0.06% | +0.42% | +35.24% | +84.59% | 49.1B | |
| -4.03% | -2.51% | +80.83% | +60.63% | 47.65B | |
| +1.19% | -3.50% | +1.46% | -10.08% | 23.8B | |
| -3.48% | -23.95% | +55.73% | +435.39% | 21.97B | |
| -1.86% | -1.15% | +41.39% | -27.50% | 17.26B | |
| -6.65% | -3.10% | +24.45% | -38.98% | 15.88B | |
| -2.83% | -1.33% | +58.86% | +208.05% | 15.77B | |
| +5.42% | +12.19% | -24.54% | +841.67% | 14.03B | |
| -1.71% | -4.73% | +39.31% | - | 13.32B | |
| Average | -1.41% | -3.25% | +42.55% | +190.08% | 22.27B | |
| Weighted average by Cap. | -1.67% | -3.47% | +42.64% | +147.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 700M 594M 544M 513M 958M 66.07B 966M 6.45B 2.52B 31.74B 2.62B 2.57B 110B | 975M 828M 758M 715M 1.33B 92.06B 1.35B 8.99B 3.5B 44.22B 3.66B 3.58B 153B |
| Net income | 27.71M 23.54M 21.55M 20.34M 37.94M 2.62B 38.27M 256M 99.64M 1.26B 104M 102M 4.34B | 242M 206M 188M 178M 332M 22.87B 334M 2.23B 871M 10.99B 909M 889M 37.93B |
| Net Debt | -7.7M -6.54M -5.99M -5.65M -10.54M -727M -10.63M -71.02M -27.68M -349M -28.89M -28.28M -1.21B | -272M -231M -212M -200M -373M -25.73B -376M -2.51B -979M -12.36B -1.02B -1B -42.66B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-05-08 | 42.60 $ | -0.14% | 2,266,025 |
| 26-05-07 | 42.66 $ | -4.69% | 10,827,662 |
| 26-05-06 | 44.76 $ | -0.09% | 2,390,245 |
| 26-05-05 | 44.80 $ | -0.24% | 3,310,824 |
| 26-05-04 | 44.91 $ | +1.79% | 2,450,608 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- TVTX Stock
Select your edition
All financial news and data tailored to specific country editions
